Data / Form D filings / Ocugen, Inc.
Ocugen, Inc.: Form D filings
Ocugen, Inc., a pharmaceuticals company in Malvern, PA, filed 5 Form D notices with the SEC between 2017 and 2018. The latest, on November 19, 2018, reports $350,400 sold of a $4 million offering to 4 investors.
Find out what Ocugen, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 5 GREAT VALLEY PARKWAY, SUITE 160, Malvern, PA, 19355
- Phone
- (484) 328-4753
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2013
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1696601
The full lists. Form D filings in Pennsylvania: 987 rows, $49.35, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 19, 2018 | New notice | $4,000,000 | $350,400 | $3,649,600 | 4 | Nov 5, 2018 | sec.gov |
| Feb 15, 2018 | New notice | $5,000,000 | $5,000,000 | $0 | 2 | Feb 1, 2018 | sec.gov |
| Jun 13, 2017 | New notice | $7,500,000 | $7,500,000 | $0 | 6 | May 23, 2017 | sec.gov |
| Feb 7, 2017 | New notice | $200,000 | $200,000 | $0 | 3 | Jun 30, 2016 | sec.gov |
| Feb 2, 2017 | New notice | $6,000,000 | $6,000,000 | $0 | 9 | Nov 17, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Susan Drexler | Executive Officer | |
| Daniel Suha Jorgensen | Executive Officer | |
| Uday Kompella | Director, Promoter | |
| Frank Leo | Director | |
| Holdings KVM | Promoter | |
| John Zhang | Director | |
| Manish Potti | Director | |
| Shankar Musunuri | Executive Officer, Director | |
| Halit Suha Taspolatoglu | Director | |
| Martin Coyne | Director |
Other pharmaceuticals companies in Pennsylvania that filed recently
- Telemachus Therapeutics, Inc. $375,000 · Oct 28, 2026
- EpiVario Inc. $185,000 · Oct 13, 2026
- Maxona Pharmaceuticals, Inc. $5.8 million · Aug 14, 2026
Every Form D from the week of Nov 19, 2018 · All recent filings in Pennsylvania · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Ocugen, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.